CorMedix to acquire nearly all of Heron Therapeutics' assets in cash-and-stock dealNov 9M&ACorMedix Inc.Heron Therapeutics, Inc. /De/Updated
Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
Heron Therapeutics signs multi-product license deal with Long Grove PharmaceuticalsSep 29PartnershipHeron Therapeutics, Inc. /De/
Heron Therapeutics extends tax benefit preservation plan to 2029Aug 14PartnershipHeron Therapeutics, Inc. /De/
Heron withdraws 2026 guidance, weighs strategic alternatives after CINVANTI rulingAug 10Quarterly updateaprepitantHeron Therapeutics, Inc. /De/